Skip to main content

HOPA Abstracts

As options for second-line therapy for patients with metastatic renal-cell carcinoma continue to expand, so does the controversy surrounding optimal treatment selection. Read More ›

As pharmacists’ responsibilities extend beyond dispensing medications to include advanced patient-centered services, many already meet the definition of nonphysician provider under Medicare Part B, yet they are often not reimbursed for their services. Read More ›

Right-to-Try Laws Challenge Pharmacy Code of Ethics
Although beneficence, autonomy, and justice comprise the bulwark of ethical principles in medicine, their prioritization has changed over the course of history. Read More ›

Page 3 of 3